Basic Info.
Type
Test Strips & Test Tube
Ethylene Oxide Sterilization
Irradiation Sterilization
Quality Guarantee Period
Two Years
Logo Printing
With Logo Printing
Product Quality Certification
CE
Medical Device Classification
Class 2
Detection Method
Colloidal Gold Method
Packing Specifications
1t/Box, 20t/Box, 25t/Box, 50t/Box
Product Description
Product Description
Product Name | Troponin I/Myoglobin/Creatine Kinase MB Detection Kit |
Detection Method | Colloidal Gold Method |
Sampling Method | serum, plasma, or whole blood |
Packing specifications | 1T/box, 20T/box, 25T/box, 50T/box |
Test Procedure
Step 1: Open the packaging box, take out the inner package, and let it equilibrate to room temperature.
Step 2: Remove the test card from the sealed pouch and use it within 1 hour after opening.
Step 3: Place the test card on a clean and level surface.
Step 4: When the test card is tested, use a straw to suck serum, plasma or whole blood and add 2-3 drops to the sample port of the test card.
Step 5: The start time is 5-15 minutes, 15 minutes after the decision is invalid.
INTERPRETATION OF ASSAY RESULTC line:
If the quality control line C appears, Means this test was successful.
If the quality control line C is not displayed, the test result is invalid regardless of whether there is a burgundy test line, and it should be tested again.
Myo
If only the quality control line C appears, and the test lines Myo are not burgundy, it indicates that no
Myo is detected, and the result is negative. Due to the limitation of detection sensitivity, negative
results may be caused by Myo concentrations lower than the analytical sensitivity of the product.
If both the quality control line C and the test line Myo appear, it indicates that Myo is detected. Samples with positive results should be confirmed with alternative testing method(s) and clinical findings before a diagnosis is made.
CKMB
If only the quality control line C appears, and the test lines CKMB are not burgundy, it indicates that no CKMB is detected, and the result is negative. Due to the limitation of detection sensitivity, negative results may be caused by CKMB concentrations lower than the analytical sensitivity of the product.
If both the quality control line C and the test line CKMB appear, it indicates that CKMB is detected. Samples with positive results should be confirmed with alternative testing method(s) and clinical findings before a diagnosis is made. cTnI
If only the quality control line C appears, and the test lines cTnI are not burgundy, it indicates that no cTnI is detected, and the result is negative. Due to the limitation of detection sensitivity, negative results may be caused by cTnI concentrations lower than the analytical sensitivity of the product.
If both the quality control line C and the test line Myo appear, it indicates that cTnI is detected. Samples with positive results should be confirmed with alternative testing method(s) and clinical findings before a diagnosis is made.
Certifications
Packaging & Shipping
Company Profile
Jinan Babio Biotechnology Co., Ltd.
Founded in 2003, Jinan Babio Biotechnology Co., Ltd. is a professional high-tech enterprise that concentrates on the R&D, manufacturing and selling of in vitro diagnostic reagents. The company was successfully listed on the NEEQ (National Equities Exchange and Quotations) in 2014 (security name: Baibo Biotechnology, stock code: 830774). The company has established a strict quality management system and passed ISO9001:2008 and ISO13485:2003 international quality system certifications. The company has internationally advanced fully automatic production equipment and a standard purification workshop of pharmaceutical grade. Baibo has strong biotechnology power and currently has more than 72 independent intellectual property rights, it undertakes a number of national scientific research projects and has 91 medical device registration certificates approved by CFDA. The company's products mainly involve sampling tubes, rapid detection kits, microbial detection reagents, POCT detection reagents, biochemical diagnostic reagents, diagnostic equipment, and so on. Babio has been actively involved in the R&D and manufacturing of sampling and testing reagents. Currently, the company's products of transport media, nasal/oral sampling swabs, and the products' quality have been recognized by the medical institutions and laboratories of various countries, In the future, Babio will be committed to providing better technology and services, and continue to struggle for the human health.
Our Advantages
FAQ
Frequently Asked Questions
1. How do I choose a suitable one?
Dear customer, please tell us your detailed needs via email or online, and we will recommend the right one according to your needs.
2. Are your prices competitive?
Dear customers, we are a manufacturer, and we guarantee to provide you with the best quality and competitive prices.
3. How do I pay?
Dear customer, we accept a variety of payment methods, such as wire transfer, Western Union...
4. When will I receive it after payment?
Dear customer, normal models can be shipped within 5-7 days, please contact us to check the shipping time to your address.
5. How to deliver?
Dear customers, we can ship by express, sea, and air.
6. Will it be damaged during transportation?
Dear customers, please don't worry, we do standard export packaging.
7. What should I do if I don't know how to use it?
Dear customers, don't worry, we have a detailed description of the use, you can also contact us to provide more service support.
For more tiered pricing based on different order quantities and customized requirements,
please do not hesitate to contact us, we are all looking forward to hearing from you very soon.
Address:
No. 1777, Dazheng Road, High-Tech Zone, Jinan City, Shandong Province
Business Type:
Manufacturer/Factory
Business Range:
Health & Medicine
Management System Certification:
ISO 9001, ISO 13485
Company Introduction:
Inan Babio Biotechnology Co., Ltd. Was established in 2003. It is a professional high-tech enterprise focusing on the research and development, production and sales of in vitro diagnostic reagents. The company was successfully listed on the New Third Board in 2014 (stock name: Baibo Bio, stock code: 830774). The company has established a strict quality management system and has passed ISO9001: 2008 and ISO13485: 2003 international quality system certification. The company has international advanced automated production equipment and pharmaceutical-grade standard purification workshops. At present, it has more than 72 independent intellectual property rights, Undertook a number of national-level scientific research projects, and has 91 medical device registration certificates approved by the State Food and Drug Administration. The company′s products mainly involve virus sampling, sterile swabs, rapid detection kits, microbial detection reagents, POCT detection reagents, biochemical diagnostic reagents, diagnostic equipment such as pregnancy test products, etc. When the global epidemic broke out in 2020, Babio was actively involved in the research and development and manufacturing of sampling and testing reagents. At present, the company′s viral vectors, nasal/oral sampling swabs and rapid The test kits have been sold to more than 56 countries. The quality of the products has been recognized by medical institutions and laboratories in various countries. The company has made contributions to the global people′s fight against the epidemic. In the future, Baibo Bio will continue to work hard to help the global epidemic prevention and control. Make a new contribution!